Trajenta 5mg Tablet 10'S

Diabetes Rx required

Best Price*  ₹ 412.00
MRP ₹515.00
(Inclusive of all taxes) *10 Tablet(s) in a Strip * Mkt: Boehringer Ingelheim India Pvt Ltd * Country of Origin: GERMANY * Delivery charges if applicable will be applied at checkout

Check Availability & Expiry



TRAJENTA 5MG contains Linagliptin which is an oral anti-diabetic agent. It is used to treat type 2 diabetes mellitus in adults when treatment with first line oral anti-diabetic medicine (such as metformin) or diet and exercise does not give adequate response. It is generally used in combination with other anti-diabetic medicines (such as metformin, glimepiride, glipizide, empagliflozin, or insulin) for better results. Type 2 diabetes is a chronic medical condition in which the body does not make enough insulin, or the produced insulin does not work well. Symptoms includes excessive urination, excessive thirst, hunger, fatigue, and blurred vision.

Linagliptin is a DPP-4 inhibitor. It helps pancreas to secrete more insulin (a hormone that digests glucose/sugar) by inhibiting an enzyme called Dipeptidyl peptidase 4, which ultimately leads to decrease in blood glucose level. Along with the treatment, follow regular exercise and diet plan as advised by your doctor to achieve better results.

TRAJENTA 5MG is strictly not recommended for use in children and adolescents under 18 years of age. Your doctor will monitor your blood sugar levels through periodic blood/urine tests. Before taking TRAJENTA 5MG inform your doctor if you have or ever had kidney disease, heart disease, or pancreas problems. TRAJENTA 5MG should be used with caution in pregnant and breast-feeding women. The most common side effects of TRAJENTA 5MG are fast heartbeat, anxiety, increased sweating, and tiredness.


  • Treat type 2 diabetes mellitus in adults


TRAJENTA 5MG effectively reduces blood glucose levels, where linagliptin acts by increasing the release of insulin (a hormone secreted by pancreas that helps in digestion) by inhibiting the activity of an enzyme called Dipeptidyl peptidase 4. As a result, the sugars present in the blood are digested by insulin, leading to a marked decrease in blood glucose level.


Take TRAJENTA 5MG with or without food. Swallow TRAJENTA 5MG as whole and do not crush or chew it. Your doctor will decide the dose and duration of the therapy depending upon your age, body weight and disease condition.



  • symptoms of low blood sugar (sweating, anxiety, blurred vision, shakiness, paleness)


  • inflamed nose or throat
  • cough
  • constipation
  • skin rash


  • blistering of skin

Stop taking TRAJENTA 5MG and contact your doctor immediately if you experience any of the following side effects:

  • severe allergic reactions (such as swelling of the face, lips, tongue, and/or throat which can lead to difficulty in breathing or swallowing)
  • signs of inflamed pancreas (stomach and back pain, nausea and vomiting)


Low blood sugar:

Try to take sugary snack or drink (in small glass) like fruit juices or sugar candy and test your sugar level after 10 minutes, if there is no change in blood sugar to the required level again try taking juices or snack. Consult your doctor if your symptoms do not improve.



It is unknown whether TRAJENTA 5MG is harmful to the unborn child and so it should be used with caution in pregnant women. Consult your doctor before taking.


It is not known whether TRAJENTA 5MG passes into human breast milk and so it should be used with caution in breastfeeding women. Consult your doctor before taking.


Do not drive or operate machinery while taking TRAJENTA 5MG, since it may cause too low blood sugar levels.


Consumption of alcohol is not recommended during treatment with TRAJENTA 5MG.


TRAJENTA 5MG should be used with caution in patients suffering from active kidney diseases. Consult your doctor for advice.


TRAJENTA 5MG should be used with caution in patients suffering from liver function impairment or active liver diseases. Consult your doctor for advice.


Do not take TRAJENTA 5MG if you are allergic to Linagliptin.


Before taking TRAJENTA 5MG, inform your doctor if you:

  • type 1 diabetes or diabetic ketoacidosis
  • symptoms of acute pancreatitis (such as severe stomach pain)
  • diabetic skin lesions

Use in pediatrics:

TRAJENTA 5MG is not recommended for use in children under 18 years of age. Consult your doctor for advice.

Use in geriatrics:

TRAJENTA 5MG can be used in elderly patients above 65 years of age with no dose adjustment needed. Consult your doctor before taking.


Before taking TRAJENTA 5MG, inform your doctor if you are taking any of the following medicines:

  • carbamazepine, phenobarbital, or phenytoin (used to treat fits (seizures) or chronic pain)
  • antibiotic such as rifampicin (used to treat infections such as tuberculosis)


If you or anyone else accidentally take too much of TRAJENTA 5MG, consult your doctor immediately. Overdosage can increase the risk of side effects.


Drug :   Linagliptin
Pharmacological Category :   Dipeptidyl Peptidase 4
Therapeutic Indication :   Type 2 diabetes mellitus
Dosage Forms :   Tablet



  • Keep out of reach of children
  • Store below 15-30°C


What is the use of TRAJENTA 5MG?

TRAJENTA 5MG is used to treat type 2 diabetes mellitus in adults, it is a condition in which the body does not make enough insulin or the insulin produced does not work properly. While taking this medicine follow proper diet regimen and exercise schedule to reduce high blood sugar levels.

Does TRAJENTA 5MG cause hypoglycaemia (low blood sugar)?

When TRAJENTA 5MG taken in combination with medicines called sulphonylureas and/or insulin, it can cause decrease in your blood sugar levels which may affect your consciousness. Your doctor may recommend frequent blood test to monitor your glucose level to minimise the risk of hypoglycaemia, especially combined with sulphonylurea and/or insulin.

How does TRAJENTA 5MG works?

TRAJENTA 5MG increases the release of insulin from the pancreas and thus decreases the hormones that raise blood sugar levels. This reduces the fasting and post meal sugar level.

Is TRAJENTA 5MG safe to use in kidney disease patients?

Yes, TRAJENTA 5MG is safe to use in patients with kidney disease and no dose adjustment is recommended for these patients.


1. KD Tripathi. Insulin, Oral Hypoglycaemic Drugs and Glucagon. Essentials of Medical Pharmacology. seventh edition.2013. Page-275

2. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. Page 2247-2248.

3. Rachael Aletti 1, Angela Cheng-Lai. Linagliptin: the newest dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus. NIH: National Library of Medicine, National center of biotechnology Information Jan-Feb 2012. [Accessed 24th March 2022]

4. Boehringer Ingelheim Pharma GmbH & Co. KG; Electronic Medicines Compendium (EMC) [Revised on June2020] [Accessed 24th March 2022]

5. Boehringer Ingelheim Pharmaceuticals, Inc 2011; U.S. Food & Drug Administration; [Revised on may2011] [Accessed 24th March 2022]


  • Glucose - Fasting Blood
  • Glucose - Postprandial Blood
  • Glycosylated Hemoglobin

Find Doctors' Answers for Common Medical Questions

trajenta 5mg how to use


    Net Qty
    1 N
    Item Weight
    17.5 g
    Hsn Code
Ondero 5mg Tablet 10'S
Prescription Diabetes Rx required

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Trajenta 5mg Tablet 10'S

Trajenta 5mg Tablet 10'S Mkt: Boehringer Ingelheim India Pvt Ltd

M.R.P.: Rs.515.00
Copyright© 2022. All Rights Reserved.